文献速递心力衰竭与心肌病

HIP-55磷酸化调控的动态相分离保护心脏免受心力衰竭

Phosphorylation-Regulated Dynamic Phase Separation of HIP-55 Protects Against Heart Failure.
PubMed 文献 · Circulation · 2024-02-08

本研究探讨HIP-55磷酸化调控的液-液相分离在心力衰竭中的作用。通过基因敲除和心脏特异性过表达小鼠及体外实验,发现HIP-55相分离受AKT介导的S269和T291位点磷酸化动态调控,该动态相分离通过抑制β肾上腺素受体介导的P38/MAPK信号通路 hyperactivation 来保护心脏,而磷酸化缺陷突变导致异常聚集并丧失保护作用。

要点

  • HIP-55心脏特异性过表达可减轻β肾上腺素能过度激活诱导的心力衰竭。
  • AKT磷酸化HIP-55 S269/T291位点动态调控其相分离,防止异常聚集。
  • HIP-55动态相分离通过抑制β肾上腺素受体-P38/MAPK通路发挥心脏保护作用。

核心结论

  • HIP-55的磷酸化调控动态相分离可保护心脏对抗交感/肾上腺素能系统介导的心力衰竭。

研究设计与样本

  • 研究采用荧光漂白恢复实验、差示干涉对比分析、pull-down、免疫荧光和免疫组化检测HIP-55的相分离能力及动态调控。
  • 使用HIP-55基因敲除小鼠和心脏特异性过表达HIP-55小鼠研究其对β肾上腺素受体过度激活诱导心力衰竭的作用。
  • 通过突变分析和特定磷酸化位点突变小鼠鉴定磷酸化调控动态相分离在心力衰竭中的作用。

主要发现

  • HIP-55基因敲除加重心力衰竭,而心脏特异性过表达HIP-55显著减轻心力衰竭。
  • HIP-55具有强相分离能力,其相分离受AKT介导的S269和T291位点磷酸化动态调控。
  • 磷酸化失败导致HIP-55动态相分离受损,形成异常聚集。
  • 长期交感神经过度激活应激诱导HIP-55 S269和T291磷酸化降低,相分离失调并形成HIP-55聚集体。
  • HIP-55动态相分离在抑制β肾上腺素受体介导的P38/MAPK信号通路过度激活中起重要作用。

临床怎么用

  • 靶向HIP-55的AKT磷酸化位点(S269/T291)以维持其动态相分离,可能成为心力衰竭治疗策略。
  • 避免HIP-55磷酸化缺陷导致的异常聚集,以防丧失心脏保护作用。

局限性

  • 研究主要基于小鼠模型和体外实验,结论外推至人类需进一步验证。
  • 未提供具体样本量、P值等统计细节,影响证据强度评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Heart failure (HF), which is the terminal stage of many cardiovascular diseases, is associated with low survival rates and a severe financial burden. The mechanisms, especially the molecular mechanism combined with new theories, underlying the pathogenesis of HF remain elusive. We demonstrate that phosphorylation-regulated dynamic liquid-liquid phase separation of HIP-55 (hematopoietic progenitor kinase 1-interacting protein of 55 kDa) protects against HF. METHODS: Fluorescence recovery after photobleaching assay, differential interference contrast analysis, pull-down assay, immunofluorescence, and immunohistochemical analysis were used to investigate the liquid-liquid phase separation capacity of HIP-55 and its dynamic regulation in vivo and in vitro. Mice with genetic deletion of HIP-55 and mice with cardiac-specific overexpression of HIP-55 were used to examine the role of HIP-55 on β-adrenergic receptor hyperactivation-induced HF. Mutation analysis and mice with specific phospho-resistant site mutagenesis were used to identify the role of phosphorylation-regulated dynamic liquid-liquid phase separation of HIP-55 in HF. RESULTS: Genetic deletion of HIP-55 aggravated HF, whereas cardiac-specific overexpression of HIP-55 significantly alleviated HF in vivo. HIP-55 possesses a strong capacity for phase separation. Phase separation of HIP-55 is dynamically regulated by AKT-mediated phosphorylation at S269 and T291 sites, failure of which leads to impairment of HIP-55 dynamic phase separation by formation of abnormal aggregation. Prolonged sympathetic hyperactivation stress induced decreased phosphorylation of HIP-55 S269 and T291, dysregulated phase separation, and subsequent aggregate formation of HIP55. Moreover, we demonstrated the important role of dynamic phase separation of HIP-55 in inhibiting hyperactivation of the β-adrenergic receptor-mediated P38/MAPK (mitogen-activated protein kinase) signaling pathway. A phosphorylation-deficient HIP-55 mutation, which undergoes massive phase separation and forms insoluble aggregates, loses the protective activity against HF. CONCLUSIONS: Our work reveals that the phosphorylation-regulated dynamic phase separation of HIP-55 protects against sympathetic/adrenergic system-mediated heart failure.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Jiang, Gu, Niu, et al. Phosphorylation-Regulated Dynamic Phase Separation of HIP-55 Protects Against Heart Failure. Circulation. 2024. PMID: 38328928. doi:10.1161/CIRCULATIONAHA.123.067519

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。